 | • レポートコード：QFJ1-4724 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、ポイントオブケア感染症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（HIV POC、クロストリジウムディフィシルPOC、HBV POC、肺炎/連鎖球菌関連感染症、呼吸器合胞体ウイルス（RSV）POC、HPV POC、インフルエンザPOC、HCV POC、MRSA POC、TB＆薬剤耐性結核POC）、用途別市場規模（病院、クリニック、在宅、生活支援医療施設、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ポイントオブケア感染症の市場動向 ・企業の競争状況、市場シェア ・ポイントオブケア感染症の種類別市場規模と予測2016-2027（HIV POC、クロストリジウムディフィシルPOC、HBV POC、肺炎/連鎖球菌関連感染症、呼吸器合胞体ウイルス（RSV）POC、HPV POC、インフルエンザPOC、HCV POC、MRSA POC、TB＆薬剤耐性結核POC） ・ポイントオブケア感染症の用途別市場規模と予測2016-2027（病院、クリニック、在宅、生活支援医療施設、研究所、その他） ・ポイントオブケア感染症の北米市場規模2016-2027（アメリカ、カナダ） ・ポイントオブケア感染症の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ポイントオブケア感染症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ポイントオブケア感染症の中南米市場規模2016-2027（メキシコ、ブラジル） ・ポイントオブケア感染症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Siemens Healthineers、Trivitron Healthcare、F. Hoffmann-La Roche Ltd、Abbott、Quest Diagnostics, Inc、BD & Company、Chembio Diagnostics Inc、Trinity Biotech、Cardinal Health、Bio-Rad Labs Inc.、bioMérieux SA、Thermo Fisher Scientific Inc、Sight Diagnostics Ltd.、Gene POC、Ortho-Clinical Diagnostics、OJ-Bio Ltd.） ・結論 |
A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system, has a rapid turnaround time (approximately 15 min), and provides actionable information that can lead to a change in patient management.
Market Analysis and Insights: Global Point of Care Infectious Disease Market
The global Point of Care Infectious Disease market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Point of Care Infectious Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Point of Care Infectious Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Point of Care Infectious Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Point of Care Infectious Disease market.
Global Point of Care Infectious Disease Scope and Market Size
Point of Care Infectious Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Point of Care Infectious Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and drug-resistant TB POC
Segment by Application
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Siemens Healthineers
Trivitron Healthcare
F. Hoffmann-La Roche Ltd
Abbott
Quest Diagnostics, Inc
BD & Company
Chembio Diagnostics Inc
Trinity Biotech
Cardinal Health
Bio-Rad Labs Inc.
bioMérieux SA
Thermo Fisher Scientific Inc
Sight Diagnostics Ltd.
Gene POC
Ortho-Clinical Diagnostics
OJ-Bio Ltd.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care Infectious Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 HIV POC
1.2.3 Clostridium difficile POC
1.2.4 HBV POC
1.2.5 Pneumonia or Streptococcus associated infections
1.2.6 Respiratory syncytial virus (RSV) POC
1.2.7 HPV POC
1.2.8 Influenza/Flu POC
1.2.9 HCV POC
1.2.10 MRSA POC
1.2.11 TB and drug-resistant TB POC
1.3 Market by Application
1.3.1 Global Point of Care Infectious Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home
1.3.5 Assisted Living Healthcare Facilities
1.3.6 Laboratories
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Point of Care Infectious Disease Market Perspective (2016-2027)
2.2 Point of Care Infectious Disease Growth Trends by Regions
2.2.1 Point of Care Infectious Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Point of Care Infectious Disease Historic Market Share by Regions (2016-2021)
2.2.3 Point of Care Infectious Disease Forecasted Market Size by Regions (2022-2027)
2.3 Point of Care Infectious Disease Industry Dynamic
2.3.1 Point of Care Infectious Disease Market Trends
2.3.2 Point of Care Infectious Disease Market Drivers
2.3.3 Point of Care Infectious Disease Market Challenges
2.3.4 Point of Care Infectious Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care Infectious Disease Players by Revenue
3.1.1 Global Top Point of Care Infectious Disease Players by Revenue (2016-2021)
3.1.2 Global Point of Care Infectious Disease Revenue Market Share by Players (2016-2021)
3.2 Global Point of Care Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Point of Care Infectious Disease Revenue
3.4 Global Point of Care Infectious Disease Market Concentration Ratio
3.4.1 Global Point of Care Infectious Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care Infectious Disease Revenue in 2020
3.5 Point of Care Infectious Disease Key Players Head office and Area Served
3.6 Key Players Point of Care Infectious Disease Product Solution and Service
3.7 Date of Enter into Point of Care Infectious Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point of Care Infectious Disease Breakdown Data by Type
4.1 Global Point of Care Infectious Disease Historic Market Size by Type (2016-2021)
4.2 Global Point of Care Infectious Disease Forecasted Market Size by Type (2022-2027)
5 Point of Care Infectious Disease Breakdown Data by Application
5.1 Global Point of Care Infectious Disease Historic Market Size by Application (2016-2021)
5.2 Global Point of Care Infectious Disease Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Point of Care Infectious Disease Market Size (2016-2027)
6.2 North America Point of Care Infectious Disease Market Size by Type
6.2.1 North America Point of Care Infectious Disease Market Size by Type (2016-2021)
6.2.2 North America Point of Care Infectious Disease Market Size by Type (2022-2027)
6.2.3 North America Point of Care Infectious Disease Market Size by Type (2016-2027)
6.3 North America Point of Care Infectious Disease Market Size by Application
6.3.1 North America Point of Care Infectious Disease Market Size by Application (2016-2021)
6.3.2 North America Point of Care Infectious Disease Market Size by Application (2022-2027)
6.3.3 North America Point of Care Infectious Disease Market Size by Application (2016-2027)
6.4 North America Point of Care Infectious Disease Market Size by Country
6.4.1 North America Point of Care Infectious Disease Market Size by Country (2016-2021)
6.4.2 North America Point of Care Infectious Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Point of Care Infectious Disease Market Size (2016-2027)
7.2 Europe Point of Care Infectious Disease Market Size by Type
7.2.1 Europe Point of Care Infectious Disease Market Size by Type (2016-2021)
7.2.2 Europe Point of Care Infectious Disease Market Size by Type (2022-2027)
7.2.3 Europe Point of Care Infectious Disease Market Size by Type (2016-2027)
7.3 Europe Point of Care Infectious Disease Market Size by Application
7.3.1 Europe Point of Care Infectious Disease Market Size by Application (2016-2021)
7.3.2 Europe Point of Care Infectious Disease Market Size by Application (2022-2027)
7.3.3 Europe Point of Care Infectious Disease Market Size by Application (2016-2027)
7.4 Europe Point of Care Infectious Disease Market Size by Country
7.4.1 Europe Point of Care Infectious Disease Market Size by Country (2016-2021)
7.4.2 Europe Point of Care Infectious Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Point of Care Infectious Disease Market Size (2016-2027)
8.2 Asia-Pacific Point of Care Infectious Disease Market Size by Type
8.2.1 Asia-Pacific Point of Care Infectious Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Point of Care Infectious Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Point of Care Infectious Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific Point of Care Infectious Disease Market Size by Application
8.3.1 Asia-Pacific Point of Care Infectious Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Point of Care Infectious Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Point of Care Infectious Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Point of Care Infectious Disease Market Size by Region
8.4.1 Asia-Pacific Point of Care Infectious Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Point of Care Infectious Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Point of Care Infectious Disease Market Size (2016-2027)
9.2 Latin America Point of Care Infectious Disease Market Size by Type
9.2.1 Latin America Point of Care Infectious Disease Market Size by Type (2016-2021)
9.2.2 Latin America Point of Care Infectious Disease Market Size by Type (2022-2027)
9.2.3 Latin America Point of Care Infectious Disease Market Size by Type (2016-2027)
9.3 Latin America Point of Care Infectious Disease Market Size by Application
9.3.1 Latin America Point of Care Infectious Disease Market Size by Application (2016-2021)
9.3.2 Latin America Point of Care Infectious Disease Market Size by Application (2022-2027)
9.3.3 Latin America Point of Care Infectious Disease Market Size by Application (2016-2027)
9.4 Latin America Point of Care Infectious Disease Market Size by Country
9.4.1 Latin America Point of Care Infectious Disease Market Size by Country (2016-2021)
9.4.2 Latin America Point of Care Infectious Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point of Care Infectious Disease Market Size (2016-2027)
10.2 Middle East & Africa Point of Care Infectious Disease Market Size by Type
10.2.1 Middle East & Africa Point of Care Infectious Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Point of Care Infectious Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Point of Care Infectious Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa Point of Care Infectious Disease Market Size by Application
10.3.1 Middle East & Africa Point of Care Infectious Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Point of Care Infectious Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Point of Care Infectious Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Point of Care Infectious Disease Market Size by Country
10.4.1 Middle East & Africa Point of Care Infectious Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Point of Care Infectious Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Siemens Healthineers
11.1.1 Siemens Healthineers Company Details
11.1.2 Siemens Healthineers Business Overview
11.1.3 Siemens Healthineers Point of Care Infectious Disease Introduction
11.1.4 Siemens Healthineers Revenue in Point of Care Infectious Disease Business (2016-2021)
11.1.5 Siemens Healthineers Recent Development
11.2 Trivitron Healthcare
11.2.1 Trivitron Healthcare Company Details
11.2.2 Trivitron Healthcare Business Overview
11.2.3 Trivitron Healthcare Point of Care Infectious Disease Introduction
11.2.4 Trivitron Healthcare Revenue in Point of Care Infectious Disease Business (2016-2021)
11.2.5 Trivitron Healthcare Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Details
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Point of Care Infectious Disease Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Point of Care Infectious Disease Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Abbott Business Overview
11.4.3 Abbott Point of Care Infectious Disease Introduction
11.4.4 Abbott Revenue in Point of Care Infectious Disease Business (2016-2021)
11.4.5 Abbott Recent Development
11.5 Quest Diagnostics, Inc
11.5.1 Quest Diagnostics, Inc Company Details
11.5.2 Quest Diagnostics, Inc Business Overview
11.5.3 Quest Diagnostics, Inc Point of Care Infectious Disease Introduction
11.5.4 Quest Diagnostics, Inc Revenue in Point of Care Infectious Disease Business (2016-2021)
11.5.5 Quest Diagnostics, Inc Recent Development
11.6 BD & Company
11.6.1 BD & Company Company Details
11.6.2 BD & Company Business Overview
11.6.3 BD & Company Point of Care Infectious Disease Introduction
11.6.4 BD & Company Revenue in Point of Care Infectious Disease Business (2016-2021)
11.6.5 BD & Company Recent Development
11.7 Chembio Diagnostics Inc
11.7.1 Chembio Diagnostics Inc Company Details
11.7.2 Chembio Diagnostics Inc Business Overview
11.7.3 Chembio Diagnostics Inc Point of Care Infectious Disease Introduction
11.7.4 Chembio Diagnostics Inc Revenue in Point of Care Infectious Disease Business (2016-2021)
11.7.5 Chembio Diagnostics Inc Recent Development
11.8 Trinity Biotech
11.8.1 Trinity Biotech Company Details
11.8.2 Trinity Biotech Business Overview
11.8.3 Trinity Biotech Point of Care Infectious Disease Introduction
11.8.4 Trinity Biotech Revenue in Point of Care Infectious Disease Business (2016-2021)
11.8.5 Trinity Biotech Recent Development
11.9 Cardinal Health
11.9.1 Cardinal Health Company Details
11.9.2 Cardinal Health Business Overview
11.9.3 Cardinal Health Point of Care Infectious Disease Introduction
11.9.4 Cardinal Health Revenue in Point of Care Infectious Disease Business (2016-2021)
11.9.5 Cardinal Health Recent Development
11.10 Bio-Rad Labs Inc.
11.10.1 Bio-Rad Labs Inc. Company Details
11.10.2 Bio-Rad Labs Inc. Business Overview
11.10.3 Bio-Rad Labs Inc. Point of Care Infectious Disease Introduction
11.10.4 Bio-Rad Labs Inc. Revenue in Point of Care Infectious Disease Business (2016-2021)
11.10.5 Bio-Rad Labs Inc. Recent Development
11.11 bioMérieux SA
11.11.1 bioMérieux SA Company Details
11.11.2 bioMérieux SA Business Overview
11.11.3 bioMérieux SA Point of Care Infectious Disease Introduction
11.11.4 bioMérieux SA Revenue in Point of Care Infectious Disease Business (2016-2021)
11.11.5 bioMérieux SA Recent Development
11.12 Thermo Fisher Scientific Inc
11.12.1 Thermo Fisher Scientific Inc Company Details
11.12.2 Thermo Fisher Scientific Inc Business Overview
11.12.3 Thermo Fisher Scientific Inc Point of Care Infectious Disease Introduction
11.12.4 Thermo Fisher Scientific Inc Revenue in Point of Care Infectious Disease Business (2016-2021)
11.12.5 Thermo Fisher Scientific Inc Recent Development
11.13 Sight Diagnostics Ltd.
11.13.1 Sight Diagnostics Ltd. Company Details
11.13.2 Sight Diagnostics Ltd. Business Overview
11.13.3 Sight Diagnostics Ltd. Point of Care Infectious Disease Introduction
11.13.4 Sight Diagnostics Ltd. Revenue in Point of Care Infectious Disease Business (2016-2021)
11.13.5 Sight Diagnostics Ltd. Recent Development
11.14 Gene POC
11.14.1 Gene POC Company Details
11.14.2 Gene POC Business Overview
11.14.3 Gene POC Point of Care Infectious Disease Introduction
11.14.4 Gene POC Revenue in Point of Care Infectious Disease Business (2016-2021)
11.14.5 Gene POC Recent Development
11.15 Ortho-Clinical Diagnostics
11.15.1 Ortho-Clinical Diagnostics Company Details
11.15.2 Ortho-Clinical Diagnostics Business Overview
11.15.3 Ortho-Clinical Diagnostics Point of Care Infectious Disease Introduction
11.15.4 Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Business (2016-2021)
11.15.5 Ortho-Clinical Diagnostics Recent Development
11.16 OJ-Bio Ltd.
11.16.1 OJ-Bio Ltd. Company Details
11.16.2 OJ-Bio Ltd. Business Overview
11.16.3 OJ-Bio Ltd. Point of Care Infectious Disease Introduction
11.16.4 OJ-Bio Ltd. Revenue in Point of Care Infectious Disease Business (2016-2021)
11.16.5 OJ-Bio Ltd. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Point of Care Infectious Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of HIV POC
Table 3. Key Players of Clostridium difficile POC
Table 4. Key Players of HBV POC
Table 5. Key Players of Pneumonia or Streptococcus associated infections
Table 6. Key Players of Respiratory syncytial virus (RSV) POC
Table 7. Key Players of HPV POC
Table 8. Key Players of Influenza/Flu POC
Table 9. Key Players of HCV POC
Table 10. Key Players of MRSA POC
Table 11. Key Players of TB and drug-resistant TB POC
Table 12. Global Point of Care Infectious Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 13. Global Point of Care Infectious Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 14. Global Point of Care Infectious Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 15. Global Point of Care Infectious Disease Market Share by Regions (2016-2021)
Table 16. Global Point of Care Infectious Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 17. Global Point of Care Infectious Disease Market Share by Regions (2022-2027)
Table 18. Point of Care Infectious Disease Market Trends
Table 19. Point of Care Infectious Disease Market Drivers
Table 20. Point of Care Infectious Disease Market Challenges
Table 21. Point of Care Infectious Disease Market Restraints
Table 22. Global Point of Care Infectious Disease Revenue by Players (2016-2021) & (US$ Million)
Table 23. Global Point of Care Infectious Disease Market Share by Players (2016-2021)
Table 24. Global Top Point of Care Infectious Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point of Care Infectious Disease as of 2020)
Table 25. Ranking of Global Top Point of Care Infectious Disease Companies by Revenue (US$ Million) in 2020
Table 26. Global 5 Largest Players Market Share by Point of Care Infectious Disease Revenue (CR5 and HHI) & (2016-2021)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Point of Care Infectious Disease Product Solution and Service
Table 29. Date of Enter into Point of Care Infectious Disease Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Point of Care Infectious Disease Market Size by Type (2016-2021) (US$ Million)
Table 32. Global Point of Care Infectious Disease Revenue Market Share by Type (2016-2021)
Table 33. Global Point of Care Infectious Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 34. Global Point of Care Infectious Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 35. Global Point of Care Infectious Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 36. Global Point of Care Infectious Disease Revenue Market Share by Application (2016-2021)
Table 37. Global Point of Care Infectious Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 38. Global Point of Care Infectious Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 39. North America Point of Care Infectious Disease Market Size by Type (2016-2021) (US$ Million)
Table 40. North America Point of Care Infectious Disease Market Size by Type (2022-2027) & (US$ Million)
Table 41. North America Point of Care Infectious Disease Market Size by Application (2016-2021) (US$ Million)
Table 42. North America Point of Care Infectious Disease Market Size by Application (2022-2027) & (US$ Million)
Table 43. North America Point of Care Infectious Disease Market Size by Country (2016-2021) & (US$ Million)
Table 44. North America Point of Care Infectious Disease Market Size by Country (2022-2027) & (US$ Million)
Table 45. Europe Point of Care Infectious Disease Market Size by Type (2016-2021) (US$ Million)
Table 46. Europe Point of Care Infectious Disease Market Size by Type (2022-2027) & (US$ Million)
Table 47. Europe Point of Care Infectious Disease Market Size by Application (2016-2021) (US$ Million)
Table 48. Europe Point of Care Infectious Disease Market Size by Application (2022-2027) & (US$ Million)
Table 49. Europe Point of Care Infectious Disease Market Size by Country (2016-2021) & (US$ Million)
Table 50. Europe Point of Care Infectious Disease Market Size by Country (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Point of Care Infectious Disease Market Size by Type (2016-2021) (US$ Million)
Table 52. Asia-Pacific Point of Care Infectious Disease Market Size by Type (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Point of Care Infectious Disease Market Size by Application (2016-2021) (US$ Million)
Table 54. Asia-Pacific Point of Care Infectious Disease Market Size by Application (2022-2027) & (US$ Million)
Table 55. Asia-Pacific Point of Care Infectious Disease Market Size by Region (2016-2021) & (US$ Million)
Table 56. Asia-Pacific Point of Care Infectious Disease Market Size by Region (2022-2027) & (US$ Million)
Table 57. Latin America Point of Care Infectious Disease Market Size by Type (2016-2021) (US$ Million)
Table 58. Latin America Point of Care Infectious Disease Market Size by Type (2022-2027) & (US$ Million)
Table 59. Latin America Point of Care Infectious Disease Market Size by Application (2016-2021) (US$ Million)
Table 60. Latin America Point of Care Infectious Disease Market Size by Application (2022-2027) & (US$ Million)
Table 61. Latin America Point of Care Infectious Disease Market Size by Country (2016-2021) & (US$ Million)
Table 62. Latin America Point of Care Infectious Disease Market Size by Country (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Point of Care Infectious Disease Market Size by Type (2016-2021) (US$ Million)
Table 64. Middle East & Africa Point of Care Infectious Disease Market Size by Type (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Point of Care Infectious Disease Market Size by Application (2016-2021) (US$ Million)
Table 66. Middle East & Africa Point of Care Infectious Disease Market Size by Application (2022-2027) & (US$ Million)
Table 67. Middle East & Africa Point of Care Infectious Disease Market Size by Country (2016-2021) & (US$ Million)
Table 68. Middle East & Africa Point of Care Infectious Disease Market Size by Country (2022-2027) & (US$ Million)
Table 69. Siemens Healthineers Company Details
Table 70. Siemens Healthineers Business Overview
Table 71. Siemens Healthineers Point of Care Infectious Disease Product
Table 72. Siemens Healthineers Revenue in Point of Care Infectious Disease Business (2016-2021) & (US$ Million)
Table 73. Siemens Healthineers Recent Development
Table 74. Trivitron Healthcare Company Details
Table 75. Trivitron Healthcare Business Overview
Table 76. Trivitron Healthcare Point of Care Infectious Disease Product
Table 77. Trivitron Healthcare Revenue in Point of Care Infectious Disease Business (2016-2021) & (US$ Million)
Table 78. Trivitron Healthcare Recent Development
Table 79. F. Hoffmann-La Roche Ltd Company Details
Table 80. F. Hoffmann-La Roche Ltd Business Overview
Table 81. F. Hoffmann-La Roche Ltd Point of Care Infectious Disease Product
Table 82. F. Hoffmann-La Roche Ltd Revenue in Point of Care Infectious Disease Business (2016-2021) & (US$ Million)
Table 83. F. Hoffmann-La Roche Ltd Recent Development
Table 84. Abbott Company Details
Table 85. Abbott Business Overview
Table 86. Abbott Point of Care Infectious Disease Product
Table 87. Abbott Revenue in Point of Care Infectious Disease Business (2016-2021) & (US$ Million)
Table 88. Abbott Recent Development
Table 89. Quest Diagnostics, Inc Company Details
Table 90. Quest Diagnostics, Inc Business Overview
Table 91. Quest Diagnostics, Inc Point of Care Infectious Disease Product
Table 92. Quest Diagnostics, Inc Revenue in Point of Care Infectious Disease Business (2016-2021) & (US$ Million)
Table 93. Quest Diagnostics, Inc Recent Development
Table 94. BD & Company Company Details
Table 95. BD & Company Business Overview
Table 96. BD & Company Point of Care Infectious Disease Product
Table 97. BD & Company Revenue in Point of Care Infectious Disease Business (2016-2021) & (US$ Million)
Table 98. BD & Company Recent Development
Table 99. Chembio Diagnostics Inc Company Details
Table 100. Chembio Diagnostics Inc Business Overview
Table 101. Chembio Diagnostics Inc Point of Care Infectious Disease Product
Table 102. Chembio Diagnostics Inc Revenue in Point of Care Infectious Disease Business (2016-2021) & (US$ Million)
Table 103. Chembio Diagnostics Inc Recent Development
Table 104. Trinity Biotech Company Details
Table 105. Trinity Biotech Business Overview
Table 106. Trinity Biotech Revenue in Point of Care Infectious Disease Business (2016-2021) & (US$ Million)
Table 107. Trinity Biotech Recent Development
Table 108. Cardinal Health Company Details
Table 109. Cardinal Health Business Overview
Table 110. Cardinal Health Point of Care Infectious Disease Product
Table 111. Cardinal Health Revenue in Point of Care Infectious Disease Business (2016-2021) & (US$ Million)
Table 112. Cardinal Health Recent Development
Table 113. Bio-Rad Labs Inc. Company Details
Table 114. Bio-Rad Labs Inc. Business Overview
Table 115. Bio-Rad Labs Inc. Point of Care Infectious Disease Product
Table 116. Bio-Rad Labs Inc. Revenue in Point of Care Infectious Disease Business (2016-2021) & (US$ Million)
Table 117. Bio-Rad Labs Inc. Recent Development
Table 118. bioMérieux SA Company Details
Table 119. bioMérieux SA Business Overview
Table 120. bioMérieux SA Point of Care Infectious Disease Product
Table 121. bioMérieux SA Revenue in Point of Care Infectious Disease Business (2016-2021) & (US$ Million)
Table 122. bioMérieux SA Recent Development
Table 123. Thermo Fisher Scientific Inc Company Details
Table 124. Thermo Fisher Scientific Inc Business Overview
Table 125. Thermo Fisher Scientific Inc Point of Care Infectious Disease Product
Table 126. Thermo Fisher Scientific Inc Revenue in Point of Care Infectious Disease Business (2016-2021) & (US$ Million)
Table 127. Thermo Fisher Scientific Inc Recent Development
Table 128. Sight Diagnostics Ltd. Company Details
Table 129. Sight Diagnostics Ltd. Business Overview
Table 130. Sight Diagnostics Ltd. Point of Care Infectious Disease Product
Table 131. Sight Diagnostics Ltd. Revenue in Point of Care Infectious Disease Business (2016-2021) & (US$ Million)
Table 132. Sight Diagnostics Ltd. Recent Development
Table 133. Gene POC Company Details
Table 134. Gene POC Business Overview
Table 135. Gene POC Point of Care Infectious Disease Product
Table 136. Gene POC Revenue in Point of Care Infectious Disease Business (2016-2021) & (US$ Million)
Table 137. Gene POC Recent Development
Table 138. Ortho-Clinical Diagnostics Company Details
Table 139. Ortho-Clinical Diagnostics Business Overview
Table 140. Ortho-Clinical Diagnostics Point of Care Infectious Disease Product
Table 141. Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Business (2016-2021) & (US$ Million)
Table 142. Ortho-Clinical Diagnostics Recent Development
Table 143. OJ-Bio Ltd. Company Details
Table 144. OJ-Bio Ltd. Business Overview
Table 145. OJ-Bio Ltd. Point of Care Infectious Disease Product
Table 146. OJ-Bio Ltd. Revenue in Point of Care Infectious Disease Business (2016-2021) & (US$ Million)
Table 147. OJ-Bio Ltd. Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Point of Care Infectious Disease Market Share by Type: 2020 VS 2027
Figure 2. HIV POC Features
Figure 3. Clostridium difficile POC Features
Figure 4. HBV POC Features
Figure 5. Pneumonia or Streptococcus associated infections Features
Figure 6. Respiratory syncytial virus (RSV) POC Features
Figure 7. HPV POC Features
Figure 8. Influenza/Flu POC Features
Figure 9. HCV POC Features
Figure 10. MRSA POC Features
Figure 11. TB and drug-resistant TB POC Features
Figure 12. Global Point of Care Infectious Disease Market Share by Application: 2020 VS 2027
Figure 13. Hospitals Case Studies
Figure 14. Clinics Case Studies
Figure 15. Home Case Studies
Figure 16. Assisted Living Healthcare Facilities Case Studies
Figure 17. Laboratories Case Studies
Figure 18. Others Case Studies
Figure 19. Point of Care Infectious Disease Report Years Considered
Figure 20. Global Point of Care Infectious Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 21. Global Point of Care Infectious Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 22. Global Point of Care Infectious Disease Market Share by Regions: 2020 VS 2027
Figure 23. Global Point of Care Infectious Disease Market Share by Regions (2022-2027)
Figure 24. Global Point of Care Infectious Disease Market Share by Players in 2020
Figure 25. Global Top Point of Care Infectious Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point of Care Infectious Disease as of 2020
Figure 26. The Top 10 and 5 Players Market Share by Point of Care Infectious Disease Revenue in 2020
Figure 27. Global Point of Care Infectious Disease Revenue Market Share by Type (2016-2021)
Figure 28. Global Point of Care Infectious Disease Revenue Market Share by Type (2022-2027)
Figure 29. North America Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. North America Point of Care Infectious Disease Market Share by Type (2016-2027)
Figure 31. North America Point of Care Infectious Disease Market Share by Application (2016-2027)
Figure 32. North America Point of Care Infectious Disease Market Share by Country (2016-2027)
Figure 33. United States Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Canada Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Europe Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Europe Point of Care Infectious Disease Market Share by Type (2016-2027)
Figure 37. Europe Point of Care Infectious Disease Market Share by Application (2016-2027)
Figure 38. Europe Point of Care Infectious Disease Market Share by Country (2016-2027)
Figure 39. Germany Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. France Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. U.K. Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Italy Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Russia Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Nordic Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Asia-Pacific Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Asia-Pacific Point of Care Infectious Disease Market Share by Type (2016-2027)
Figure 47. Asia-Pacific Point of Care Infectious Disease Market Share by Application (2016-2027)
Figure 48. Asia-Pacific Point of Care Infectious Disease Market Share by Region (2016-2027)
Figure 49. China Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Japan Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. South Korea Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Southeast Asia Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. India Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Australia Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Latin America Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Latin America Point of Care Infectious Disease Market Share by Type (2016-2027)
Figure 57. Latin America Point of Care Infectious Disease Market Share by Application (2016-2027)
Figure 58. Latin America Point of Care Infectious Disease Market Share by Country (2016-2027)
Figure 59. Mexico Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Brazil Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Middle East & Africa Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Middle East & Africa Point of Care Infectious Disease Market Share by Type (2016-2027)
Figure 63. Middle East & Africa Point of Care Infectious Disease Market Share by Application (2016-2027)
Figure 64. Middle East & Africa Point of Care Infectious Disease Market Share by Country (2016-2027)
Figure 65. Turkey Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 66. Saudi Arabia Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 67. UAE Point of Care Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 68. Siemens Healthineers Revenue Growth Rate in Point of Care Infectious Disease Business (2016-2021)
Figure 69. Trivitron Healthcare Revenue Growth Rate in Point of Care Infectious Disease Business (2016-2021)
Figure 70. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Point of Care Infectious Disease Business (2016-2021)
Figure 71. Abbott Revenue Growth Rate in Point of Care Infectious Disease Business (2016-2021)
Figure 72. Quest Diagnostics, Inc Revenue Growth Rate in Point of Care Infectious Disease Business (2016-2021)
Figure 73. BD & Company Revenue Growth Rate in Point of Care Infectious Disease Business (2016-2021)
Figure 74. Chembio Diagnostics Inc Revenue Growth Rate in Point of Care Infectious Disease Business (2016-2021)
Figure 75. Trinity Biotech Revenue Growth Rate in Point of Care Infectious Disease Business (2016-2021)
Figure 76. Cardinal Health Revenue Growth Rate in Point of Care Infectious Disease Business (2016-2021)
Figure 77. Bio-Rad Labs Inc. Revenue Growth Rate in Point of Care Infectious Disease Business (2016-2021)
Figure 78. bioMérieux SA Revenue Growth Rate in Point of Care Infectious Disease Business (2016-2021)
Figure 79. Thermo Fisher Scientific Inc Revenue Growth Rate in Point of Care Infectious Disease Business (2016-2021)
Figure 80. Sight Diagnostics Ltd. Revenue Growth Rate in Point of Care Infectious Disease Business (2016-2021)
Figure 81. Gene POC Revenue Growth Rate in Point of Care Infectious Disease Business (2016-2021)
Figure 82. Ortho-Clinical Diagnostics Revenue Growth Rate in Point of Care Infectious Disease Business (2016-2021)
Figure 83. OJ-Bio Ltd. Revenue Growth Rate in Point of Care Infectious Disease Business (2016-2021)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
世界の感染症用診療現場診断市場規模・現状・予測（2021年-2027年） Point-of-care diagnosis is a test performed on the site of patient care that provides immediate results.Infectious diseases are caused by various microorganisms, such as viruses, bacteria, fungi and parasites.Instant diagnosis of infectious diseases can improve disease management and detection, redu…- 世界の医療関連感染症診断市場規模・現状・予測（2021年-2027年） Diagnosis of health care-associated infectious diseases. Diagnosis of health care-associated infectious diseases. Market Analysis and Insights: Global Healthcare-associated Infectious Disease Diagnostics Market The global Healthcare-associated Infectious Disease Diagnostics market size is projected …
- 世界の感染症治療薬市場規模・現状・予測（2021年-2027年） Infectious Disease Drugs are drugs that relieve symptoms, resolve symptoms, or block the route of transmission. The epidemic of infectious diseases has risen, spending has increased to increase the penetration of treatments for these diseases, initiatives to increase treatment awareness and awarenes…
- 世界の呼吸器合胞体ウイルス（RSV）治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Respiratory Syncytial Virus(RSV) Therapeutics Market The global Respiratory Syncytial Virus(RSV) Therapeutics market size is projected to reach US$ 837.5 million by 2027, from US$ 564.7 million in 2020, at a CAGR of 5.7% during 2021-2027. With industry-standard a…
- 世界の感染症診断市場規模・現状・予測（2021年-2027年） Infectious Diseases Diagnosis is used for confirmation of a disease that can be spreaded in form of a quick, precise test result. Market Analysis and Insights: Global Infectious Disease Diagnosis Market The global Infectious Disease Diagnosis market size is projected to reach US$ XX million by 2027,…